Contribution of the serine kinase c-Jun N-terminal kinase (JNK) to oxidant-induced insulin resistance in isolated rat skeletal muscle

References

• Abdul-Ghani MA, DeFronzo RA. (2010). Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol 2010: Article ID 476279, 19 pages; doi:10.1155/2010/476279.
   PubMedGoogle Scholar
• Archuleta TL, Lemieux AM, Saengsirisuwan V, Teachey MK, Lindborg KA, Kim JS, Henriksen EJ. (2009). Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK. Free Radic Biol Med 47:1486–93.
   PubMed Web of Science ®Google Scholar
• Bennett BL, Sasaki DT, Murray BW, et al. (2001). SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci 98:13681–6.
   PubMed Web of Science ®Google Scholar
• Blair AS, Hajduch E, Litherland GJ, Hundal HS. (1999) Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress: Evidence for cross talk between the insulin and SAPK2/p38 mitogen activated-protein kinase signaling pathways. J Biol Chem 274:36293–9.
   PubMed Web of Science ®Google Scholar
• Cirialdi TP, Nikoulina SE, Bandukwalam RA, Carter L, Henry RR. (2007). Role of glycogen synthase kinase-3α in insulin action in cultured human muscle cells. Endocrinology 148:4393–9.
   PubMed Web of Science ®Google Scholar
• Davies KJ. (1995). Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 61:1–31.
   PubMedGoogle Scholar
• DeFronzo RA, Ferrannini E. (1991). Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–94.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. (1997). Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diab Rev 5:177–269.
   Google Scholar
• DeFronzo RA. (2004). Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88:787–835.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. (2009). From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773–95.
   PubMed Web of Science ®Google Scholar
• Diamond-Stanic MK, Marchionne EM, Teachey MK, Durazo DE, Kim JS, Henriksen EJ. (2011). Critical role of transient p38 MAPK activation in skeletal muscle insulin resistance caused by low-level in vitro oxidant stress. Biochem Biophys Res Commun, 405:439–444.
   PubMed Web of Science ®Google Scholar
• Dokken BB, Henriksen EJ. (2006). Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in pre-diabetic obese Zucker rats. Am J Physiol Endocrinol Metab 291:E207–13.
   PubMed Web of Science ®Google Scholar
• Dokken BB, Sloniger JA, Henriksen EJ. (2005). Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle. Am J Physiol Endocrinol Metab 288:E1188–94.
   PubMed Web of Science ®Google Scholar
• Dokken BB, Saengsirisuwan V, Kim JS, Teachey MK, Henriksen EJ. (2008). Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3. Am J Physiol Endocrinol Metab 294:E615–21.
   PubMed Web of Science ®Google Scholar
• Evans JL, Goldfine ID, Maddux BA, Grodsky GM. (2002). Oxidative stress and stress activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrin Rev 23:599–622.
   PubMed Web of Science ®Google Scholar
• Hansen PA, Gulve EA, Holloszy JO. (1994). Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol 76:979–85.
   PubMed Web of Science ®Google Scholar
• Henriksen EJ, Jacob S. (1995). Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 44:267–72.
   PubMed Web of Science ®Google Scholar
• Henriksen EJ. (2010). Dysregulation of glycogen synthase kinase-3 and the etiology of insulin resistance and type 2 diabetes. Curr Diab Rev 6:285–93.
   PubMedGoogle Scholar
• Henriksen EJ, Diamond-Stanic MK, Marchionne EM. (2011). Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 51:993–9.
   PubMed Web of Science ®Google Scholar
• Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420:333–6.
   PubMed Web of Science ®Google Scholar
• Holloszy JO, Hansen PA. (1996). Regulation of glucose transport into skeletal muscle. Rev Physiol Biochem Pharmacol 128:99–193.
   PubMed Web of Science ®Google Scholar
• Kim JS, Saengsirisuwan V, Sloniger JA, Teachey MK, Henriksen EJ. (2006). Stimulation of muscle glucose transport by an oxidant stress: roles of insulin signaling and p38 MAP kinase. Free Radic Biol Med 41:818–24.
   PubMed Web of Science ®Google Scholar
• Li Y-P, Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB. (2005). TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 19:362–70.
   PubMed Web of Science ®Google Scholar
• Nikoulina SE, Cirialdi TP, Mudaliar S, Carter L, Johnson K, Henry RR. (2002). Inhibition of glycogen synthase kinase-3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51:2190–98.
   PubMed Web of Science ®Google Scholar
• Sies H. (1997). Oxidative stress: Oxidants and antioxidants. Exp Physiol 82:291–5.
   PubMed Web of Science ®Google Scholar
• Solinas G, Karin M. (2010). JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction. FASEB J 24:2596–611.
   PubMed Web of Science ®Google Scholar
• Zierath JR, Krook A, Wallberg-Henriksson H. (2000). Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43:821–35.
   PubMed Web of Science ®Google Scholar